New Acquisitions In Health Care And Safety Will Expand Market Presence In 2024

Published
09 Feb 25
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
UK£26.39
9.6% undervalued intrinsic discount
20 Aug
UK£23.84
Loading
1Y
-31.3%
7D
2.1%

Author's Valuation

UK£26.4

9.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 13%

Shared on23 Apr 25
Fair value Decreased 10%

AnalystConsensusTarget has decreased revenue growth from 2.4% to 1.8%.

Shared on17 Apr 25
Fair value Decreased 2.52%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.97%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 3.75%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 2.89%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.085%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 29%

AnalystConsensusTarget has increased revenue growth from 1.4% to 3.0%, increased future PE multiple from 20.6x to 23.8x and increased shares outstanding growth rate from -0.0% to -0.0%.